Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

First- and second-trimester uterine artery pulsatility index as a combination factor in predictive diagnosis of pregnancy-induced hypertension.

Tytuł:
First- and second-trimester uterine artery pulsatility index as a combination factor in predictive diagnosis of pregnancy-induced hypertension.
Autorzy:
Dash SS; Department of Obstetrics and Gynecology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Jena P; Department of Obstetrics and Gynecology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Khuntia S; Department of Obstetrics and Gynecology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.; MM Medicare Hospital, Cuttack, Odisha, India.
Pathak M; Research & Development Department, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Rath SK; Department of Obstetrics and Gynecology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Źródło:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2021 Sep; Vol. 154 (3), pp. 431-435. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2017- : Malden, MA : Wiley
Original Publication: [New York, NY] Hoeber Medical Division, Harper & Row, [c1969-
MeSH Terms:
Hypertension, Pregnancy-Induced*
Pre-Eclampsia*
Female ; Humans ; Pregnancy ; Pregnancy Trimester, First ; Pregnancy Trimester, Second ; Prospective Studies ; Ultrasonography, Prenatal ; Uterine Artery/diagnostic imaging
References:
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122-1131.
Agrawal S, Walia GK. Prevalence and risk factors for symptoms suggestive of pre-eclampsia in Indian women. J Womens Health. 2014;3:1-9.
Agrawal S, Walia GK, Staines UE, Casas JP, Millett C. Prevalence of and risk factors for eclampsia in pregnant women in India. Family Med Com Health. 2016;5:225-244.
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-1074.
Montgomery AL, Ram U, Kumar R, Jha P; The Million Death Study Collaborators. Maternal mortality in India: causes and healthcare service use based on a nationally representative survey. PLoS One. 2014;9:1-11.
Schwarze A, Nelles I, Krapp M, et al. Doppler ultrasound of the uterine artery in the prediction of severe complications during low risk pregnancies. Br J Obstet Gynaecol. 2000;107(2):196-208.
Redman CW, Sargent IL. Latest advances in understanding precclampsia. Science. 2005;308:1592-1594.
Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin Nephrol. 2017;37:386-397.
Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466-480.
Rolnik DL, Wright D, Poon LCY, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50:492-495.
Tan MY, Wright D, Syngelaki A, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51:743-750.
Tan MY, Poon LC, Rolnik DL, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52:52-59.
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. Special Issue. 2019;145(1):1-33.
Khalil A, Nicolaides KH. How to record uterine artery Doppler in the first trimester. Ultrasound Obstet Gynaecol. 2013;4:478-479.
Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynaecol. 2008;32:128-132.
Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & Management recommendations for international practice (ISSHP). Pregnancy Hypertension. 2018;13:291-310.
Muti M, Tshimanga M, Notion GT, Bangure D, Chonzi P. Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovasc Disord. 2015;15:11.
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565-572.
Alves JAG, Silva BYDC, Sousa PCPD, Maia SB, Costa FDS. Reference range of uterine artery Doppler parameters between the 11th and 14th pregnancy weeks in a population sample from Northeast Brazil. Revista Brasileira de Ginecologia e Obstetricia. 2013;35:357-362.
Papageorghiou AT, Yu CK, Bindra R, Pandis G; Fetal Medicine Foundation Second Trimester Screening Group. Multicentre screening for preeclampsia and fetal growth restriction by transvginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18(5):441-449.
Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre eclampsia and intra uterine growth restriction: a systematic review and bivariable meta analysis. Can Med Assoc J. 2008;178(6):701-711.
Prajapati J, Saloni R. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler, and mean arterial pressure (a prospective study of 200 cases). J Obstet Gynaecol India. 2013;63(1):32-36.
Espinoza J, Kusanovic JP, Bahado-Singh R, et al. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small for gestational age and gestational hypertension? J Ultrasound Med. 2010;29(7):1103-1115.
Contributed Indexing:
Keywords: hypertensive disorder of pregnancy; pre-eclampsia; pregnancy-induced hypertension; pulsatility index; uterine artery pulsatility index
Entry Date(s):
Date Created: 20201216 Date Completed: 20210819 Latest Revision: 20210819
Update Code:
20240105
DOI:
10.1002/ijgo.13545
PMID:
33326607
Czasopismo naukowe
Objective: Hypertensive disorder of pregnancy is a major cause of fetal and maternal morbidity and mortality. The current approach for pregnancy-induced hypertension (PIH) screening is complex and expensive. The present prospective cohort study assesses the advantage of combining first- and second-trimester uterine artery pulsatility index (UAPI) for predictive diagnosis of PIH.
Methods: A total of 151 prenatal cases in their first trimester were studied and followed up till delivery. The mean UAPI was calculated for the first and second trimesters during the nuchal translucency and anomaly scans. Receiver operating characteristic analysis was used to calculate the cut-off of UAPI for first-trimester, second-trimester, and both trimesters combined.
Results: Twenty-seven (17.9%) pregnant women developed PIH. Mean ± SD UAPI values for first and second trimesters were 1.92 ± 0.60 and 1.23 ± 0.36, respectively. The cut-offs for abnormal UAPI were ≥2.51, ≥1.32, and ≥1.91 for first trimester, second trimester, and both trimesters combined, respectively. The sensitivity and specificity of UAPI in predictive diagnosis of PIH were 82% and 95% for first trimester, 93% and 85% for the second trimester, and 93% and 98% for both trimesters combined.
Conclusion: Combining UAPI of first and second trimesters improves the predictive diagnosis of PIH, which can be carried out during the nuchal translucency and anomaly scans without imparting extra cost to the patient.
(© 2021 International Federation of Gynecology and Obstetrics.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies